In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of ...
The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
After its approval, the first OTC product didn't actually hit store shelves until September 2023. This followed decades of ...
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the most ...
Providing access to naloxone and appropriate training can protect workers and possibly save someone's life, says ISEA.
Incannex Healthcare Inc., a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of a pre-investigational new drug meeting with the U.S. Food and Drug ...
About CannQuit-O CannQuit-O is a chewable tablet with unique characteristics provided by novel combination of registered/FDA-approved polymers allowing for rapid and sustained release of its active ...
The FDA has even approved for public sale devices that administer fixed doses of naloxone for opioid overdose and epinephrine ...
Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone ...
Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company ...
In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of Narcan nasal spray -- a medication that rapidly reverses fentanyl overdose.